Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Mainz, June 2017 – We are pleased to announce that our close cooperation partner BioNTech has today published an article in Nature Medicine.

The paper entitled “Elimination of large tumors in mice by mRNA-encoded bispecific antibodies” reports preclinical data featuring their novel class of mRNA-encoded antibody drugs called RiboMABs® and describes the application of their technology for mRNA-based in vivo delivery of T cell-engaging bispecific antibodies.

For further information please refer to the BioNTech website and the relevant press releases as well as the article in Nature Medicine.